light activated photodynamic compound vaccine (Theralase Technologies/University of Manitoba)

N/A

Report date: 2025/01/26 18:01:20

Base Information

Drug Namelight activated photodynamic compound vaccine (Theralase Technologies/University of Manitoba)
Drug Alias Namelight activated PDC vaccine (Theralase Technologies/University of Manitoba)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheralase Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of ManitobaTheralase Technologies IncPublic Health Agency Of Canada
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A